TomoTherapy Reports Fourth Quarter Financial Results (Centre Daily Times)
TomoTherapy Incorporated (NASDAQ:TOMO) today released financial results for the fourth quarter ended December 31, 2007. TomoTherapy has developed, markets and sells the Hi-Art(R) treatment system, an advanced and versatile radiation therapy system for the treatment of a wide variety of cancers.

Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia (The San Francisco Examiner)
CORONA, Calif. ( Map ) - CORONA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, today announced that its New Drug Application (NDA) for silodosin, a novel alpha(1)- adrenoreceptor antagonist, has been accepted for filing by the U.S. Food and Drug Administration (FDA). Watson is seeking marketing approval of ...